Unexpected formation of N-methylfulleropyrrolidines by the reaction of fullerene and gossypol and their bioactivity

Carbon

Volumn 47, Issue 12, 2009, Pages 2883-2888

  Yin, Juanjuan ^a   Nigh, Michael ^a   Vanderveer, Don ^a   Jiang, Yueming ^b   Wang, Xi ^a   Chen, Feng ^a  

^a CLEMSON UNIVERSITY   (United States)

^b SOUTH CHINA INSTITUTE OF BOTANY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

DOSE-DEPENDENT; FULLEROPYRROLIDINES; IN-VITRO ASSAYS; INDUCED APOPTOSIS; PRATO REACTION; RADICAL SCAVENGING ACTIVITY; SARCOSINE; STRUCTURE DETERMINATION;

ALDEHYDES; CELL DEATH; FULLERENES;

X RAY CRYSTALLOGRAPHY;

EID: 67949100354     PISSN: 00086223     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.carbon.2009.06.034     Document Type: Article

References (30)

1. Hirsch A. The chemistry of the fullerenes (1994), Thieme Medical Publishers, New York
2. Jensen A.W., Wilson S.R., and Schuster D.I. Biological applications of fullerenes. Bioorg Med Chem 4 (1996) 767-779
3. DaRos T., and Prato M. Medicinal chemistry with fullerenes and fullerene derivatives. Chem Commun (1999) 663-669
4. 10 as a MRI contrast agent. J Am Chem Soc 125 (2003) 5471-5478
5. Zhou S., Burger C., Chu B., Sawamura M., Nagahama N., Toganoh M., et al. Spherical bilayer vesicles of fullerene-based surfactants in water: a laser light scattering study. Science 291 (2001) 1944-1947
6. Marcorin G.L., DaRos T., Castellano S., Stefancich G., Bonin I., Miertus S., et al. Design and synthesis of novel [60] fullerene derivatives as potential HIV aspartic protease inhibitors. Org Lett 2 (2000) 3955-3958
7. Friedman S.H., Ganapathi P.S., Rubin Y., and Kenyon G.L. Optimizing the binding of fullerene inhibitors of the HIV-1 protease through predicted increases in hydrophobic desolvation. J Med Chem 41 (1998) 2424-2429
8. Zhu W.Z., Schuster D.I., and Tuckerman M.E. Molecular dynamics study of the connection between flap closing and binding of fullerene-based inhibitors of the HIV-1 protease. Biochemistry 42 (2003) 1326-1333
9. Mashino T., Nishikawa D., Takahashi K., Usui N., Yamori T., Seki M., et al. Antibacterial and antiproliferative activity of cationic fullerene derivatives. Bioorg Med Chem Lett 24 (2003) 4395-4397
10. Gonzalez K.A., Wilson L.J., Wu W.J., and Nancollas G.H. The differential cytotoxicity of water-soluble fullerenes. Bioorg Med Chem 10 (2002) 1991-1997
11. Mirakyan A.L., and Wilson L.J. Functionalization of C60 with diphosphonate groups: a route to bone-vectored fullerenes. J Chem Soc Perkin Trans 2 (2002) 1173-1176
12. 60H type). Chem Commun (2005) 3041-3043
13. 70 derivatives. J Org Chem 71 (2006) 2267-2271
14. 60: synthesis, characterization, and functionalization of fullerene pyrrolidines. J Am Chem Soc 115 (1993) 9798-9799
15. Georgakilas V., Kordatos K., Prato M., Guldi D.M., Holzinger M., and Hirsch A. Organic functionalization of carbon nanotubes. J Am Chem Soc 124 (2002) 760-761
16. Kenar J.A. Reaction chemistry of gossypol and its derivatives. J Am Oil Chem Soc 83 (2006) 269-302
17. Radloff R.J., Deck L.M., Royer R.E., and Vander Jagt D.L. Antiviral activities of gossypol and its derivatives against Herpes Simplex Virus Type II. Pharmacol Res Commun 18 (1986) 1063-1073
18. Lin T.S., Schinazi R.F., Zhu J., Birks E., Carbone R., Si Y., et al. Anti-HIV-1 activity and cellular pharmacology of various analogs of gossypol. Biochem Pharmacol 46 (1993) 251-255
19. Gonzalez-Garza T., Matlin S.A., Mata-Cardenas B.D., and Said-Fernandez S. In vitro evaluation of gossypol as potential antiamoebic drug. Proc West Pharmacol Soc 34 (1991) 359-361
20. Blanco A., Aoki A., Montamat E.E., and Rovai L.E. Effect of gossypol upon motility and ultrastructure of Trypanosoma cruzi. J Protozool 30 (1983) 648-651
21. Gerez de Burgos N.M., Burgos C., Montamat E.E., Rovai L.E., and Blanco A. Inhibition by gossypol of oxidoreductases from Trypanosoma cruzi. Biochem Pharmacol 33 (1984) 955-959
22. Montamat E.E., Burgos C., Gerez de Burgos N.M., Rovai L.E., Blanco A., and Segura E.L. Inhibitory action of gossypol on enzymes and growth of Trypanosoma cruzi. Science 218 (1982) 288-289
23. Adams R., Morris R.C., and Kirkpatrick E.C. Structure of gossypol. IX. Oxidation and degradation of gossypol hexamethyl ether; gossic acid. J Am Chem Soc 60 (1938) 2170-2174
24. Adams R., and Dial W.R. Structure of gossypol. XXII. Gossypol ethers and their reduction products. J Am Chem Soc 61 (1939) 2077-2082
25. Clark E.P. Gossypol. III. The oxidation of gossypol. J Biol Chem 77 (1928) 81-87
26. Dowd M.K., and Pelitire S.M. Isolation of 6-methoxy gossypol and 6,6′-dimethoxy gossypol from Gossypium barbadense SeaIsland cotton. J Agric Food Chem 54 (2006) 3265-3270
27. Zhou D.J., Zhao Y.L., Gan L.B., Luo C.P., and Huang C.H. Compound 1 can also be prepared by the reaction of fullerene, sarcosine and benzaldehyde, and compound 3 can be synthesized by the reaction of fullerene, sarcosine and acetone. Chem J Chinese U 5 (1997) 665-670
28. 60: synthesis, characterization, and functionalization of fullerene pyrrolidines. J Am Chem Soc 115 (1993) 9798-9799
29. Haas R.H., and Shirley D.A. Oxidation of gossypol. II. Formation of gossypolone with ferric chloride. J Org Chem 30 (1965) 4111-4113
30. Dawson T.M., Dawson V.L., and Snyder S.H. Immunosuppressant FK506 enhances phosphorylation of nitric oxide synthase and protects against glutamate neurotoxicity. Annu Neurol 32 (1992) 297-311